We sought to elucidate the role of AKT in folliclestimulating hormone (FSH)-mediated granulosa cell (GC) differentiation. Our results define a signaling pathway in GCs whereby the inactivating phosphorylation of tuberin downstream of phosphatidylinositol (PI) 3-kinase/AKT activity leads to Rheb (Ras homolog enriched in brain) and subsequent mTOR (mammalian target of rapamycin) activation. mTOR then stimulates translation by phosphorylating p70 S6 kinase and, consequently, the 40 S ribosomal protein S6. Activation of this pathway is required for FSH-mediated induction of several follicular differentiation markers, including luteinizing-hormone receptor (LHR), inhibin-␣, microtubuleassociated protein 2D, and the PKA type II regulatory subunit. FSH also promotes activation of the transcription factor hypoxia-inducible factor-1 (HIF-1). FSHstimulated HIF-1 activity is inhibited by the PI 3-kinase inhibitor LY294002, the Rheb inhibitor FTI-277 (farnesyltransferase inhibitor-277), and the mTOR inhibitor rapamycin. Finally, we find that the FSH-mediated upregulation of reporter activities for LHR, inhibin-␣, and vascular endothelial growth factor is dependent upon HIF-1 activity, because a dominant negative form of HIF-1␣ interferes with the up-regulation of these genes. These results show that FSH enhances HIF-1 activity downstream of the PI 3-kinase/AKT/Rheb/mTOR pathway in GCs and that HIF-1 activity is necessary for FSH to induce multiple follicular differentiation markers.The anterior pituitary hormone follicle-stimulating hormone (FSH) 1 provides the key stimulus that promotes proliferation and differentiation of the ovarian follicle to the pre-ovulatory phenotype (1, 2 FSH signaling results in increased transcription of a number of characteristic follicular differentiation markers, including the steroidogenic enzymes side-chain cleavage cytochrome P-450 and aromatase cytochrome P-450 (12), the luteinizing hormone receptor (LHR) (3), inhibin-␣ (13), the signaling intermediates microtubule-associated protein 2D (MAP2D) (14), and the PKA type II regulatory subunit (RII) (15). FSH also stimulates antrum formation and angiogenesis in the peripheral follicle thecal cells mediated in part by the vascular endothelial growth factor (VEGF) (16,17). Our investigation into the mechanisms by which two of these FSH targets, MAP2D and RII, are up-regulated in response to FSH revealed that their up-regulation at the protein level is blocked by the PI 3-kinase inhibitors LY294002 and wortmannin. FSH-mediated PI 3-kinase activation is also necessary for the expression of the cartilage link protein (8) in GCs and for optimal transferrin secretion and lactate production by Sertoli cells (9). In support of a role for PI 3-kinase/AKT activity in GC differentiation, insulin-like growth factor-1 (IGF-1), which activates the PI 3-kinase/AKT pathway via the IGF-1 receptor (18), synergizes with FSH in GCs to increase the expression of LHR (19), inhibin-␣ (20), and side-chain cleavage cytochrome P-450 and is sufficient for the expres...
Ovarian follicles undergo exponential growth in response to follicle-stimulating hormone (FSH), largely as a result of the proliferation of granulosa cells (GCs). In vitro under serum-free conditions, rat GCs differentiate in response to FSH but do not proliferate unless activin is also present. In the presence of FSH plus activin, GCs exhibit enhanced expression of cyclin D2 as well as inhibin-alpha, aromatase, steroidogenic factor-1 (SF-1), cholesterol side chain (SCC), and epiregulin. In this report we sought to identify the signaling pathways by which FSH and activin promote GC proliferation and differentiation. Our results show that these responses are associated with prolonged Akt phosphorylation relative to time-matched controls and are dependent on phosphatidylinositol 3-kinase (PI 3-kinase) and Smad2/3 signaling, based on the ability of the PI 3-kinase inhibitor LY294002 or infection with adenoviral dominant negative Smad3 (DN-Smad3) mutant to attenuate induction of cyclin D2, inhibin-alpha, aromatase, SCC, SF-1, and epiregulin. The DN-Smad3 mutant also abolished prolonged Akt phosphorylation stimulated by FSH plus activin 24 h post-treatment. Infection with the adenoviral constitutively active forkhead box-containing protein, O subfamily (FOXO)1 mutant suppressed induction of cyclin D2, aromatase, inhibin-alpha, SF-1, and epiregulin. Transient transfections of GCs with constitutively active FOXO1 mutant also suppressed cyclin D2, inhibin-alpha, and epiregulin promoter-reporter activities. Chromatin immunoprecipitation results demonstrate in vivo the association of FOXO1 with the cyclin D2 promoter in untreated GCs and release of FOXO1 from the cyclin D2 promoter upon addition of FSH plus activin. These results suggest that proliferation and differentiation of GCs in response to FSH plus activin requires both removal of FOXO1-dependent repression and positive signaling from Smad2/3.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.